There are currently oral medications available for the treatment of neocoronitis, such as ritonavir tablets, some of which are still in the clinical trial stage. In the latest guideline for the treatment of new crown pneumonia, ritonavir tablets are used as oral drugs for the treatment of new crown pneumonia. Although they are not targeted specific drugs, they have been proved to have a significant reduction in the mortality rate in overseas clinics. At the same time, some drugs are also in the clinical phase 1 to 3 of the experimental stage, such as Azulfidine, Fabipiravir, etc., may have a killing effect on the new crown virus, but the specific cure rate, adverse reactions, etc. need to wait for the results of the clinical trials, may be based on the situation of the epidemic will be expedited to the market, the specific to the official notice shall prevail. [Tip] This article refers to the “new coronary pneumonia, new coronary virus pneumonia”, etc., has been December 26, 2022, the National Health Commission issued a notice to change the name to “new coronary virus infection”.